The Department of Veterans Affairs (VA), through Network Contracting Office 15, is seeking bids for the procurement of Fexofenadine HCl 60mg medication to be delivered to the Tucson Consolidated Mail Outpatient Pharmacy (CMOP). The solicitation number is 36C77025Q0093, with a response deadline set for January 10, 2025, at 3 PM Central Time. The contract is categorized as a Small Business Set-Aside, and offers are to be submitted via email to the designated Contract Specialist, Jennifer Coleman.
Interested vendors must comply with the Drug Supply Chain Security Act (DSCSA), submitting their state wholesale distributor license along with their quotes. Submissions should include a signed solicitation cover page, a price schedule in Excel format, and a Buy American Act (BAA) certificate indicating the country of origin for the products. The estimated issue date for the solicitation is January 3, 2025, and delivery is expected within ten days after receipt of the order. This presolicitation notice invites responsible sources to participate in meeting the ongoing pharmaceutical needs of veterans.
The document pertains to a solicitation issued by the Department of Veterans Affairs for a pharmaceutical supply contract, specifically for the Tucson Consolidated Mail Outpatient Pharmacy (CMOP). The requisition outlines a detailed request for offers (RFP), specifying requirements, pricing schedules, delivery protocols, and compliance clauses. The contract emphasizes the importance of providing pharmaceuticals that meet strict regulatory and quality standards, including barcoding and therapeutic equivalence. Offerors are instructed to submit detailed quotes, including pricing in Excel format and relevant legal documentation. Delivery logistics are crucial, mandating coordination with CMOP to adhere to operational hours and tracking procedures. The document incorporates various Federal Acquisition Regulation (FAR) clauses, underlining contractual obligations and compliance requirements for contractors serving federal entities. The content highlights the government's focus on efficient procurement processes, aiming to supply high-quality pharmaceuticals while ensuring adherence to legal and safety standards during the acquisition process.
The document outlines a Request for Quote (RFQ) from the CMOP Tucson facility, identified as RFQ 36C77025Q0093, for a specific pharmaceutical product, Fexofenadine HCL 60MG (500CT). Vendors must submit their proposals by January 10, 2025, at 3:00 PM CT, including a signed SF1449 solicitation cover page, a completed quote spreadsheet, a valid wholesale distributor license, and OEM authorization for OTC products. Additionally, a Buy American Act certificate is required. All submitted quotes must adhere to stipulations regarding expiration dates, ensuring that products have a minimum shelf life of one year upon delivery. Vendors are allowed to propose one quote only and must provide details in the comments section regarding any variations in quantities or expiration dates. The document emphasizes compliance with regulatory requirements and the procurement process for pharmaceuticals, reflecting the government's commitment to maintaining standards in sourcing medical supplies.